Plasmodium spp. is the etiological agent of malaria, a life-threatening parasitic disease
transmitted by infected mosquitoes. Malaria remains a major global health challenge …

With the support of modern biotechnology, vaccine technology continues to iterate. The
safety and efficacy of vaccines are some of the most important areas of development in the …

A neutral polysaccharide (POPAN) from Portulaca oleracea L. was isolated with alkali and
purified to obtain. HPLC analysis suggested POPAN (40.9 kDa) was mainly composed of …

Malaria as vector-borne disease remains important health concern with over 200 million
cases globally. Novel antimalarial medicines and more effective vaccines must be …

Malaria, a mosquito‐borne parasitic infection caused by protozoan parasites belonging to
the genus Plasmodium, is a dangerous disease that contributes to millions of hospital visits …

Despite the critical role of the Anopheles innate immune system in defending against
Plasmodium infection, there is still limited information about the key immune mechanisms in …

Control of complex parasites via vaccination remains challenging, with the current
combination of vaccines and small drugs remaining the choice for an integrated control …

The development and creation of a new generation vaccines based on recombinant proteins
that assemble into virus-like particles (VLPs), as well as recombinant proteins in the form of …

Malaria remains a leading cause of childhood mortality, thereby highlighting the need for an
effective vaccine. R21 is a virus-like particle-based (VLP-based) vaccine displaying the …

Plasmodium spp. is the etiological agent of malaria, a life-threatening parasitic disease
transmitted by infected mosquitoes. Malaria remains a major global health challenge …